We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

235 hedge funds and large institutions have $1.59B invested in Supernus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 28

34% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 67

10% more capital invested

Capital invested by funds: $1.45B → $1.59B (+$139M)

5% more funds holding

Funds holding: 223 → 235 (+12)

1.52% more ownership

Funds ownership: 102.33% → 103.85% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

28% less call options, than puts

Call options by funds: $2.84M | Put options by funds: $3.95M

Holders
235
Holders Change
+12
Holders Change %
+5.38%
% of All Funds
3.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
90
Reduced
67
Closed
28
Calls
$2.84M
Puts
$3.95M
Net Calls
-$1.11M
Net Calls Change
-$6.27M

Top Buyers

Rank Fund Capital Flow
1
PCH
Polar Capital Holdings
United Kingdom
+$19.1M
2
SIMG
Stephens Investment Management Group
Texas
+$10.3M
3
LCG
Lisanti Capital Growth
New York
+$9.24M
4
AC
Armistice Capital
New York
+$7.16M
5
GKIM
GW&K Investment Management
Massachusetts
+$6.4M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$12.4M
2
Millennium Management
Millennium Management
New York
-$9.89M
3
HP
HealthInvest Partners
Sweden
-$8.93M
4
Invesco
Invesco
Georgia
-$8.72M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
201
Next Financial Group
Texas
$15K +$9.89K +326 +176%
Simplex Trading
202
Simplex Trading
Illinois
$12K -$196K -6,454 -94%
Rockefeller Capital Management
203
Rockefeller Capital Management
New York
$9K +$10K +331 New
S
204
SignatureFD
Georgia
$8K – – –
Fifth Third Bancorp
205
Fifth Third Bancorp
Ohio
$8K +$6.16K +203 +274%
PCG
206
Private Capital Group
Connecticut
$7K +$182 +6 +3%
TWA
207
TCI Wealth Advisors
Arizona
$7K +$334 +11 +5%
HNB
208
Huntington National Bank
Ohio
$7K +$2.58K +85 +49%
PA
209
PSI Advisors
Florida
$6K – – –
Carson Wealth (CWM LLC)
210
Carson Wealth (CWM LLC)
Nebraska
$6K +$6.1K +201 New
Daiwa Securities Group
211
Daiwa Securities Group
Japan
$5K – – –
PFBT
212
Parkside Financial Bank & Trust
Missouri
$5K +$121 +4 +2%
Bessemer Group
213
Bessemer Group
New Jersey
$5K +$4.82K +159 New
QCG
214
Quadrant Capital Group
Ohio
$4K -$637 -21 -14%
GWM
215
Geneos Wealth Management
Colorado
$4K – – –
HI
216
Harbour Investments
Wisconsin
$4K – – –
PHK
217
Point72 Hong Kong
Hong Kong
$4K +$4.1K +135 New
STCOSD
218
Sageworth Trust Company of South Dakota
South Dakota
$4K +$4.52K +149 New
C
219
Covestor
United Kingdom
$4K +$4.61K +152 New
Fuller & Thaler Asset Management
220
Fuller & Thaler Asset Management
California
$3K -$5.52K -182 -62%
SPIA
221
Steward Partners Investment Advisory
New York
$3K -$455 -15 -11%
ACM
222
Aquatic Capital Management
Illinois
$3K +$3.03K +100 New
FP
223
Financial Perspectives
Minnesota
$1.52K – – –
ST
224
Sageworth Trust
Pennsylvania
$1K -$4.67K -154 -77%
AF
225
Allworth Financial
California
$1K – – –
7 8
9
10 11

SUPN Hedge Fund Activity: Q4 2021 in Review

235 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q4 2021, worth a combined $1.59B — up 9.6% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new SUPN positions and 28 closed out — a net gain of 16 holders — while 90 added to existing stakes and 67 trimmed.

The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $19.1M. The largest seller was BlackRock, cutting an estimated $12.4M.

  • 235 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q4 2021, up from 223 in Q3 2021.
  • Funds reported $1.59B of Supernus Pharmaceuticals stock for Q4 2021, up 9.6% quarter-over-quarter.
  • 44 funds opened new Supernus Pharmaceuticals positions in Q4 2021 and 28 closed out, a net change of +16 holders.
  • The largest Supernus Pharmaceuticals buyer in Q4 2021 was Polar Capital Holdings, an estimated $19.1M added.
  • The largest Supernus Pharmaceuticals seller in Q4 2021 was BlackRock, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2021.